Chlorpheniramine, an Old Drug with New Potential Clinical Applications: A Comprehensive Review of the Literature.

Chlorpheniramine allergy intranasal rhinitis urticarial viral infections

Journal

Current reviews in clinical and experimental pharmacology
ISSN: 2772-4336
Titre abrégé: Curr Rev Clin Exp Pharmacol
Pays: Netherlands
ID NLM: 9918227368306676

Informations de publication

Date de publication:
01 Jun 2022
Historique:
received: 14 04 2022
revised: 15 04 2022
accepted: 18 04 2022
entrez: 2 6 2022
pubmed: 3 6 2022
medline: 3 6 2022
Statut: aheadofprint

Résumé

Chlorpheniramine Maleate (CPM), also known as chlorphenamine, is a potent alkylamine first-generation H1 antihistamine that has been around since the 1950s. CPM is a widely popular drug commonly used to treat allergic conditions, given its antihistamine properties. Although mainly used in over-the-counter treatment for cough and colds, various studies discuss a wide range of CPM's clinical uses, such as treating asthma, plasma cell gingivitis, chronic urticaria, depression, among others. This antihistamine is usually taken orally; however, intravenous, intramuscular, and subcutaneous routes have been documented. Intranasal routes have recently been explored, especially due to its antiviral properties against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accordingly, given CPM's extensive medical and safety profile, the present review explores this versatile drug's current and potential clinical applications. Although it is widely used mainly for treating common colds and aforementioned allergic conditions, it can be concluded that CPM can be considered to be used for other clinical indications. The repurposing of CPM for other clinical indications such as COVID-19 needs to be further explored through more extensive studies.

Identifiants

pubmed: 35652393
pii: CRCEP-EPUB-124120
doi: 10.2174/2772432817666220601162006
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Syed A A Rizvi (SAA)

Department of Pharmaceutical Sciences, Hampton University School of Pharmacy (HUSOP), Hampton, VA, USA.

Gustavo Ferrer (G)

Pulmonary Critical Care, Aventura Hospital and Medical Center, Aventura, USA.

Uzzam Ahmed Khawaja (UA)

Jinnah Medical and Dental College, Karachi, Pakistan.

Marcos A Sanchez-Gonzalez (MA)

Lake Erie College of Osteopathic Medicine, Bradenton, FL, USA.

Classifications MeSH